<DOC>
	<DOCNO>NCT00768638</DOCNO>
	<brief_summary>Randomized control double blind study parallel group evaluate comparative effect low-dose atorvastatin proteinuria patient stage 3 4 chronic kidney disease .</brief_summary>
	<brief_title>Study Atorvastatin Dose Dependent Reduction Proteinuria</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Age 18 Stage 3 4 chronic kidney disease ( modify MDRD ) proteinuria &gt; 1g/d ACEi and/or ARB , proteinuria &gt; 1g/d intolerance contraindication ACEi and/or ARB blood pressure &lt; 130/80 mmHg &lt; 140/90 mmHg patient five antihypertensive drug stable renal function rapid progression renal failure immunosuppressive therapy within past 3 month need renal replacement therapy within 8 month definite history chronic liver disease , abnormal liver function evidence active inflammatory muscle disease definite previous adverse reaction statin concurrent treatment contraindicate drug ( fibrate , macrolide antibiotic , systemic use imidazole triazole antifungal , proteaseinhibitors , ciclosporin ) child bear potential know poorly compliant clinic visit prescribe medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Chronic kidney disease</keyword>
</DOC>